Jakub has been working exclusively within Life Sciences since 2019, initially leading recruitment teams and service offerings before transitioning into global business development. Holding a degree in Law, he applies a rigorous analytical framework to the complexities of the regulatory landscape and possesses deep knowledge of the drug development lifecycle.
At Apotech, Jakub supports the Regulatory Business unit with a focus on delivering complete compliance across EU and FDA submissions, medical writing, and marketing authorisation. He works with Biopharma organisations to navigate the regulatory requirements of clinical development through to post-approval modifications and full life cycle management. Fluent in English and Polish, Jakub is dedicated to helping clients achieve regulatory certainty across the US, EU, and global markets through effective, high-calibre delivery models.